Outcomes of safety and effectiveness in a multicenter randomized, controlled trial of whole-body hypothermia for neonatal hypoxic-ischemic encephalopathy
- PMID: 18829776
- PMCID: PMC2819143
- DOI: 10.1542/peds.2008-0456
Outcomes of safety and effectiveness in a multicenter randomized, controlled trial of whole-body hypothermia for neonatal hypoxic-ischemic encephalopathy
Abstract
Background: Whole-body hypothermia reduced the frequency of death or moderate/severe disabilities in neonates with hypoxic-ischemic encephalopathy in a randomized, controlled multicenter trial.
Objective: Our goal was to evaluate outcomes of safety and effectiveness of hypothermia in infants up to 18 to 22 months of age.
Design/methods: A priori outcomes were evaluated between hypothermia (n = 102) and control (n = 106) groups.
Results: Encephalopathy attributable to causes other than hypoxia-ischemia at birth was not noted. Inotropic support (hypothermia, 59% of infants; control, 56% of infants) was similar during the 72-hour study intervention period in both groups. Need for blood transfusions (hypothermia, 24%; control, 24%), platelet transfusions (hypothermia, 20%; control, 12%), and volume expanders (hypothermia, 54%; control, 49%) was similar in the 2 groups. Among infants with persistent pulmonary hypertension (hypothermia, 25%; control, 22%), nitric-oxide use (hypothermia, 68%; control, 57%) and placement on extracorporeal membrane oxygenation (hypothermia, 4%; control, 9%) was similar between the 2 groups. Non-central nervous system organ dysfunctions occurred with similar frequency in the hypothermia (74%) and control (73%) groups. Rehospitalization occurred among 27% of the infants in the hypothermia group and 42% of infants in the control group. At 18 months, the hypothermia group had 24 deaths, 19 severe disabilities, and 2 moderate disabilities, whereas the control group had 38 deaths, 25 severe disabilities, and 1 moderate disability. Growth parameters were similar between survivors. No adverse outcomes were noted among infants receiving hypothermia with transient reduction of temperature below a target of 33.5 degrees C at initiation of cooling. There was a trend in reduction of frequency of all outcomes in the hypothermia group compared with the control group in both moderate and severe encephalopathy categories.
Conclusions: Although not powered to test these secondary outcomes, whole-body hypothermia in infants with encephalopathy was safe and was associated with a consistent trend for decreasing frequency of each of the components of disability.
Trial registration: ClinicalTrials.gov NCT00005772.
References
-
- Robertson CMT, Finer NN, Grace MGA. School performance of survivors of neonatal encephalopathy associated with birth asphyxia at term. J Pediatr. 1989;114(5):753–760. - PubMed
-
- Shankaran S, Woldt E, Koepke T, Bedard MP, Nandyal R. Acute neonatal morbidity and long-term central nervous system sequelae of perinatal asphyxia in term infants. Early Hum Dev. 1991;25(2):135–148. - PubMed
-
- Gunn AJ, Gluckman PD, Gunn TR. Selective head cooling in newborn infants after perinatal asphyxia: a safety study. Pediatrics. 1998;102(4 pt 1):885–892. - PubMed
-
- Gluckman PD, Wyatt JS, Azzopardi D, et al. Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicenter randomised trial. Lancet. 2005;365(9460):663–670. - PubMed
-
- Eicher DJ, Wagner CL, Katikaneni LP, et al. Moderate hypothermia in neonatal encephalopathy: efficacy outcomes. Pediatr Neurol. 2005;32(1):11–17. - PubMed
Publication types
MeSH terms
Associated data
Grants and funding
- U10 HD27851/HD/NICHD NIH HHS/United States
- M01 RR 00125/RR/NCRR NIH HHS/United States
- M01RR 00039/RR/NCRR NIH HHS/United States
- M01 RR 00750/RR/NCRR NIH HHS/United States
- U10 HD040689/HD/NICHD NIH HHS/United States
- U10 HD027851/HD/NICHD NIH HHS/United States
- U01 HD36790/HD/NICHD NIH HHS/United States
- U10 HD034216/HD/NICHD NIH HHS/United States
- U10 HD040498/HD/NICHD NIH HHS/United States
- M01 RR000125/RR/NCRR NIH HHS/United States
- U10 HD027856/HD/NICHD NIH HHS/United States
- U10 HD40689/HD/NICHD NIH HHS/United States
- U10 HD021373/HD/NICHD NIH HHS/United States
- U10 HD021385/HD/NICHD NIH HHS/United States
- U10 HD 21373/HD/NICHD NIH HHS/United States
- U01 HD036790/HD/NICHD NIH HHS/United States
- U10 HD34216/HD/NICHD NIH HHS/United States
- U10 HD027880/HD/NICHD NIH HHS/United States
- U10 HD040521/HD/NICHD NIH HHS/United States
- M01 RR000039/RR/NCRR NIH HHS/United States
- U10 HD40521/HD/NICHD NIH HHS/United States
- U10 HD27880/HD/NICHD NIH HHS/United States
- M01 RR008084/RR/NCRR NIH HHS/United States
- U10 HD27904/HD/NICHD NIH HHS/United States
- U10 HD040461/HD/NICHD NIH HHS/United States
- U10 HD40498/HD/NICHD NIH HHS/United States
- U10 HD27871/HD/NICHD NIH HHS/United States
- M01 RR000044/RR/NCRR NIH HHS/United States
- M01 RR000750/RR/NCRR NIH HHS/United States
- U10 HD027853/HD/NICHD NIH HHS/United States
- U10 HD027904/HD/NICHD NIH HHS/United States
- U10 HD27856/HD/NICHD NIH HHS/United States
- M01 RR08084/RR/NCRR NIH HHS/United States
- U10 HD40461/HD/NICHD NIH HHS/United States
- U10 HD27853/HD/NICHD NIH HHS/United States
- UL1 TR000454/TR/NCATS NIH HHS/United States
- 5 M01 RR00044/RR/NCRR NIH HHS/United States
- U10 HD027871/HD/NICHD NIH HHS/United States
- M01 RR 00070/RR/NCRR NIH HHS/United States
- M01 RR 0039-43/RR/NCRR NIH HHS/United States
- M01 RR000070/RR/NCRR NIH HHS/United States
- U10 HD21385/HD/NICHD NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
